Abstract
Cancer patients are at increased risk for stroke from direct and indirect effects of their malignancy. Some tumors are at high risk for cerebrovascular complications. Certain stroke mechanisms are specific to cancer, such as compression and occlusion of cerebral vessels by tumor, coagulopathy predisposing to hemorrhage and thrombosis, and treatment-related atherosclerosis. Special consideration for these mechanisms needs to be made when evaluating cancer patients, and treatment aimed at secondary prevention needs to incorporate overall prognosis and goals of care.
Similar content being viewed by others
References and Recommended Reading
Lindvig K, Moller H, Mosbech J, Jensen OM: The pattern of cancer in a large cohort of stroke patients. Int J Epidemiol 1990, 19:498–504.
Kooiker JC, MacLean JM, Sumi SM: Cerebral embolism, marantic endocarditis, and cancer. Arch Neurol 1976, 33:260–264.
Chaturvedi S, Ansell J, Recht L: Should cerebral ischemic events in cancer patients be considered a manifestation of hypercoagulability? Stroke 1994, 25:1215–1218.
Behrendt CE, Ruiz RB: Cerebral ischemic events in patients with advanced lung or prostate cancer. Neuroepidemiology 2005, 24:230–236.
Cestari DM, Weine DM, Panageas KS, et al.: Stroke in patients with cancer: incidence and etiology. Neurology 2004, 62:2025–2030. This paper is the largest clinical series dedicated to ischemic stroke in cancer patients, retrospectively evaluating 96 patients treated at Memorial Sloan-Kettering Cancer Center.
Murata J, Sawamura Y, Takahashi A, et al.: Intracerebral hemorrhage caused by a neoplastic aneurysm from small-cell lung carcinoma: case report. Neurosurgery 1993, 32:124–126.
Graus F, Rogers LR, Posner JB: Cerebrovascular complications in patients with cancer. Medicine 1985, 64:16–35.
Glass J, Hochberg FH, Miller DC: Intravascular lymphomatosis. A systemic disease with neurologic manifestations. Cancer 1993, 71:3156–3164.
Rogers LR, Cho ES, Kempin S, Posner JB: Cerebral infarction from non-bacterial thrombotic endocarditis. Clinical and pathological study including the effects of anticoagulation. Am J Med 1987, 83:746–756.
Yu M, Nardella A, Pechet L: Screening tests of disseminated intravascular coagulation: guidelines for rapid and specific laboratory diagnosis. Crit Care Med 2000, 28:1777–1780.
Ageno W, Finazzi S, Steidl L, et al.: Plasma measurement of D-dimer levels for the early diagnosis of ischemic stroke subtypes. Arch Intern Med 2002, 162:2589–2593.
Feinberg WM, Swenson MR: Cerebrovascular complications of L-asparaginase therapy. Neurology 1988, 38:127–133.
Mitchell LG, Andrew M, Hanna K, et al.: A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with Lasparaginase: results of the Prophylactic Antithrombin Replacement in Kids with Acute Lymphoblastic Leukemia Treated with Asparaginase (PARKAA) Study. Cancer 2003, 97:508–516.
Pectasides D, Barbounis V, Athanassiou A, Mariatos P: Cerebrovascular accidents following hormonochemotherapy in cancer patients. Am J Clin Oncol 1992, 15:168–173.
Simon T, Boutouyrie P, Simon JM, et al.: Infuence of tamoxifen on carotid intima-media thickness in postmenopausal women. Circulation 2002, 106:2925–2929.
Chang J, Powles TJ, Ashley SE, et al.: The effect of tamoxifen and hormone replacement therapy on serum cholesterol, bone mineral density and coagulation factors in healthy postmenopausal women participating in a randomised, controlled tamoxifen prevention study. Ann Oncol 1996, 7:671–675.
Bushnell C: The cerebrovascular risks associated with tamoxifen use. Expert Opin Drug Saf 2005, 4:501–507. This review article discusses underlying mechanisms of thrombotic risk associated with tamoxifen use and critically presents data from several studies evaluating stroke risk with tamoxifen.
Akdal G, Donmez B, Cakmakci H, Yener GG: A case with cerebral thrombosis receiving tamoxifen treatment. Eur J Neurol 2001, 8:723–724.
Finelli PF, Schauer PK: Cerebral sinus thrombosis with tamoxifen. Neurology 2001, 56:1113–1114.
Masjuan J, Pardo J, Callejo JM, et al.: Tamoxifen: a new risk factor for cerebral sinus thrombosis. Neurology 2004, 62:334–335.
Bushnell CD, Goldstein LB: Risk of ischemic stroke with tamoxifen treatment for breast cancer: a meta-analysis. Neurology 2004, 63:1230–1233.
Coplin WM, Cochran MS, Levine SR, Crawford SW: Stroke after bone marrow transplantation: frequency, aetiology and outcome. Brain 2001, 124:1043–1051.
Haynes JC, Machtay M, Weber RS, et al.: Relative risk of stroke in head and neck carcinoma patients treated with external cervical irradiation. Laryngoscope 2002, 112:1883–1887. This study determined a 12% 5-year risk (relative risk of 2.09; P = 0.0007) of stroke following neck irradiation for head and neck cancers, correlating radiation-induced accelerated atherosclerosis as a risk factor.
Cheng SW, Wu LL, Ting AC, et al.: Irradiation-induced extracranial carotid stenosis in patients with head and neck malignancies. Am J Surg 1999, 178:323–328.
Chomette G, Auriol M, Baubion D, de Frejacques C: Non-bacterial thrombotic endocarditis. Autopsy study, clinico-pathological correlations (French). Ann Med Interne (Paris) 1980, 131:443–447.
Loire R, Tabib A, Normand JC: Non-bacterial thrombosing endocarditis (French). Arch Mal Coeur Vaiss 1981, 74:157–165.
Biller J, Challa VR, Toole JF, Howard VJ: Nonbacterial thrombotic endocarditis. A neurologic perspective of clinicopathologic correlations of 99 patients. Arch Neurol 1982, 39:95–98.
Kim HS, Suzuki M, Lie JT, Titus JL: Nonbacterial thrombotic endocarditis (NBTE) and disseminated intravascular coagulation (DIC): autopsy study of 36 patients. Arch Pathol Lab Med 1977, 101:65–68.
Kearsley JH, Tattersall MH: Cerebral embolism in cancer patients. Q J Med 1982, 51:279–291.
Tsanaclis AM, Robert F: Cerebral embolism in nonbacterial thrombotic endocarditis associated with carcinoma. A clinico-pathological study. Acta Neurol Latinoam 1976, 22:86–103.
Ojeda VJ, Frost F, Mastaglia FL: Non-bacterial thrombotic endocarditis associated with malignant disease: a clinicopathological study of 16 cases. Med J Aust 1985, 142:629–631.
Gonzalez Quintela A, Candela MJ, Vidal C, et al.: Non-bacterial thrombotic endocarditis in cancer patients. Acta Cardiol 1991, 46:1–9.
Pomerance A: Infective and non-bacterial thrombotic endocarditis. In The Pathology of the Heart. Edited by Pomerance A, Davies MJ: Oxford: Blackwell; 1975:358–366.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nguyen, T., DeAngelis, L.M. Stroke in cancer patients. Curr Neurol Neurosci Rep 6, 187–192 (2006). https://doi.org/10.1007/s11910-006-0004-0
Issue Date:
DOI: https://doi.org/10.1007/s11910-006-0004-0